Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS | NEJM - nejm.org
- Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS | NEJM nejm.org
- 'Truly remarkable' drug helps motor neurone disease BBC
- Biogen says ALS drug shows clinical benefit in new data analysis Reuters
- Investigational ALS Drug Betters Biomarkers, but Can It Improve Motor Functions? Medpage Today
- ‘Truly remarkable’ new drug slows motor neuron disease The Independent
- View Full Coverage on Google News